Corteva, Inc.

Corteva, Inc.

CTVA
Corteva, Inc.US flagNew York Stock Exchange
78.53
USD
-0.92
- -
52.52BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
18.74
19
19.06
18.47
18.99
21.27
24.22
24.3
24.37
25.59
16.97
Basic EPS, GAAP
0.67
3.38
-6.76
-1.28
0.91
2.39
1.59
1.04
1.31
1.61
-0.23
Free Cash Flow per Basic Share
- -
- -
0.64
1.43
2.76
3.71
1.21
2.5
3.09
5.01
2.49
Dividend per Share
- -
- -
3.74
0.68
0.52
0.54
0.58
0.62
0.66
0.7
-0.43
Book Value per Share
- -
- -
99.55
32.47
33.39
34.94
35.47
35.7
34.7
35.92
- -
Tangible Book Value per Share
- -
- -
69.88
3.55
5.12
7.2
8.41
6.85
6.57
8
- -
Basic Weighted Avg Shares
749
749
749
750
749
736
721
709
694
680
674
Sales/Revenue/Turnover
14,041
14,240
14,287
13,846
14,217
15,655
17,455
17,226
16,908
17,401
11,433
Operating Margin (%)
6.31
1.32
-3.14
4.22
5.93
8.41
11.05
12.25
12.4
15.05
9.86
Depreciation Expense
247
270
2,790
1,599
1,177
1,243
1,223
1,211
1,227
1,203
903
Net Income, GAAP
503
2,534
-5,065
-959
681
1,759
1,147
735
907
1,094
-152
Effective Tax Rate (%)
- -
- -
- -
- -
- -
22.34
14.73
13.91
32.31
28.67
15.5
Profit Margin (%)
3.58
17.79
-35.45
-6.93
4.79
11.24
6.57
4.27
5.36
6.29
-1.33
Working Capital
- -
- -
9,662
5,281
6,220
5,988
6,051
5,851
4,711
5,210
- -
LT Debt
- -
- -
5,784
115
1,102
1,100
1,283
2,291
1,953
1,686
- -
Total Equity
- -
- -
75,153
24,555
25,063
25,623
25,541
25,279
24,030
24,386
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
3.86
6.14
6.66
5.21
6.97
- -
Return on Capital (%)
- -
- -
- -
- -
- -
6.7
4.49
3.38
3.86
4.51
4.52
Return on Common Equity (%)
- -
- -
-13.57
-1.94
2.77
7.01
4.53
2.92
3.72
4.56
-1.17

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
894
1,674
- -
LT Borrowings
1,686
1,682
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
672
670
670
Market Capitalization
45,055
56,089
56,746

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
17,335
17,385
- -
Cash, Cash Equivalents & STI
4,530
1,966
- -
Accounts Receivable, Net
5,034
7,759
- -
Inventories
5,667
5,202
- -
Total Current Liabilities
12,125
11,854
- -
Payables & Accruals
7,652
7,407
- -
ST Debt
894
1,674
- -
Deferred Revenue
3,579
2,773
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-0.52%
1.48%
Free Cash Flow
- -
29.4%
58.79%
Net Income, GAAP
- -
26.32%
20.62%
Sales/Revenue/Turnover
- -
4.27%
2.92%
Total Cash Common Dividend
- -
4.13%
3.71%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,492
6,112
2,326
3,978
16,908
2025
4,417
6,456
2,618
3,910
17,401
2026
4,905
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.6
1.51
-0.76
-0.06
1.31
2025
0.95
1.93
-0.47
-0.82
1.61
2026
1.07
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.16
0.16
0.17
0.17
0.66
2025
0.17
1.13
-0.79
0.18
0.7
2026
0.18
- -
- -
- -
- -

Company Description

CEO
Charles Victor Magro
Full Time Employees
21,500
Sector
Basic Materials
Industry
Agricultural Inputs
Address
9330 Zionsville Road Indianapolis IN United States of America 46268
IPO Date
May 24, 2019
Business
Corteva, Inc. Corteva, Inc. (CTVA) develops and supplies advanced seed and crop protection products to enhance agricultural productivity worldwide. The company operates through two primary segments, Seed and Crop Protection; the Seed segment offers high-performance hybrid and traited seeds for row crops such as corn and soybeans under brands including Pioneer and Brevant, alongside specialty seeds for fruits, vegetables, and other crops, supported by digital selection tools and biotechnology traits for insect resistance and herbicide tolerance; the Crop Protection segment provides herbicides including the Enlist system, insecticides, fungicides, nitrogen stabilizers, seed treatments, biologicals, and pasture management solutions to combat weeds, diseases, insects, and nematodes. Corteva serves farmers and the agricultural input industry across more than 140 countries, with a focus on integrated solutions that combine genetics, chemistry, and digital agriculture technologies; it maintains a global manufacturing footprint, robust research and development investment exceeding $1.3 billion annually in genomics, biotechnology, and new active ingredients, and key brands like Pioneer, founded in 1926. Headquartered in Indianapolis, Indiana since 2022 after relocating from Delaware, the company employs over 20,000 people and traces its origins to the 2019 spin-off from DowDuPont as a pure-play agriscience entity. Recent developments include the announcement in late September 2025 of plans to separate into two independent public companies along seed and crop protection lines, with current CEO Chuck Magro to lead the crop protection spin-co; additionally, Corteva entered a strategic collaboration and joint venture with gene-editing firm Pairwise in 2024, investing $25 million in equity to advance climate-resilient crops, and reaffirmed its Delaware presence in October 2025 by relocating corporate offices to downtown Wilmington while retaining over 200 jobs.

Company News

  • Corteva Announces Effectiveness of Vylor's Form 10 Registration Statement

  • ADM vs. CTVA: Two Agricultural Leaders With Very Different Moats

  • Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole

  • 5 Agriculture Operations Stock Picks to Tap Long-Term Growth Trends

  • DOLE vs. CTVA: Which Stock Is the Better Value Option?

  • Corteva, Inc. (CTVA) Analyst/Investor Day Transcript

  • Vylor to Expand Soybean Leadership: Next-Gen Tech Platforms Maintain North America Yield Advantage, Accelerate Latin America Lineup via Broad Spectrum Insect Control

  • Vylor Confirms Breakthrough Wheat Technology Will Launch in 2027

  • Corteva (NYSE:CTVA) & Kronos Worldwide (NYSE:KRO) Financial Comparison

  • Corteva Categorically Rejects Unfounded, Unprecedented Allegations by State Attorneys General

  • Corteva Categorically Rejects Unfounded, Unprecedented Allegations by State Attorneys General

  • Corteva Board of Directors Approves Vylor Distribution

  • Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination

  • Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million

  • Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions

  • Vylor Launches Vylor Edge, New Investment Platform for Global Agriculture Innovation

  • Vylor Launches a New Era in Corn: Industry-First Yield and Yield Stability Trait, Advanced Insect Control to Deliver Step-Change in Production, Farmer Profitability

  • DOLE or CTVA: Which Is the Better Value Stock Right Now?

  • 27,374 Shares in Corteva, Inc. $CTVA Purchased by EP Wealth Advisors LLC

  • Bank of New York Mellon Corp Acquires New Stake in Corteva, Inc. $CTVA